A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy.
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Vorinostat (Primary) ; Anastrozole; Exemestane; Letrozole
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 29 Aug 2014 Status changed from completed to discontinued according to investigator correspondence.
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.